Literature DB >> 22592215

Abl kinase constructs expressed in bacteria: facilitation of structural and functional studies including segmental labeling by expressed protein ligation.

Rong Xu1, Dongsheng Liu, David Cowburn.   

Abstract

A great portion of tyrosine kinases are involved in cell development and their structural alteration is intimately involved in associated pathologies of development and oncology. These kinases are one of the major groups of targets under investigation for molecular therapeutics. To carry out biochemical and structural biological studies on these kinases, economical production of their purified forms is highly desirable. However over-expressing tyrosine kinases as recombinant forms in bacterial systems and their purification is a significant challenge. Abelson kinase (Abl) has previously been expressed on a large scale to facilitate X-ray crystallography and NMR structure studies mainly in baculovirus infected insect cells. Even though success has been achieved in expression of soluble tyrosine kinases in E. coli with chaperones to improve correct folding, low expression levels of kinases are intrinsic in such systems because of diversion of resources to produce chaperones. Here we present a straightforward method to express and purify isolated Abl kinase domain and SH3-SH2-kinase multi-domain structures. The expressed Abl protein retains its correct folding and biological function. The yield of soluble protein is in a several mg L(-1) range in minimal media. Furthermore we demonstrate that segmental isotopic labelling using expressed protein ligation can be achieved using bacterial expressed Abl kinase domain constructs, which is especially useful in NMR structure-activity studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592215      PMCID: PMC3586340          DOI: 10.1039/c2mb25051a

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  38 in total

1.  The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells.

Authors:  M W Deininger; J M Goldman; N Lydon; J V Melo
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

2.  Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.

Authors:  Mohammad Azam; Valentina Nardi; William C Shakespeare; Chester A Metcalf; Regine S Bohacek; Yihan Wang; Raji Sundaramoorthi; Piotr Sliz; Darren R Veach; William G Bornmann; Bayard Clarkson; David C Dalgarno; Tomi K Sawyer; George Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

3.  Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome.

Authors:  Junmin Peng; Joshua E Elias; Carson C Thoreen; Larry J Licklider; Steven P Gygi
Journal:  J Proteome Res       Date:  2003 Jan-Feb       Impact factor: 4.466

4.  PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.

Authors:  Nicholas C Wolff; Darren R Veach; William P Tong; William G Bornmann; Bayard Clarkson; Robert L Ilaria
Journal:  Blood       Date:  2005-01-18       Impact factor: 22.113

5.  Protein identification in DNA databases by peptide mass fingerprinting.

Authors:  P James; M Quadroni; E Carafoli; G Gonnet
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

6.  An E. coli expression system for the rapid purification and characterization of a v-abl tyrosine protein kinase.

Authors:  N B Lydon; B Adams; J F Poschet; A Gutzwiller; A Matter
Journal:  Oncogene Res       Date:  1990

7.  Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.

Authors:  B J Mayer; D Baltimore
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

8.  Structural basis for the autoinhibition of c-Abl tyrosine kinase.

Authors:  Bhushan Nagar; Oliver Hantschel; Matthew A Young; Klaus Scheffzek; Darren Veach; William Bornmann; Bayard Clarkson; Giulio Superti-Furga; John Kuriyan
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

9.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.

Authors:  B J Druker; S Tamura; E Buchdunger; S Ohno; G M Segal; S Fanning; J Zimmermann; N B Lydon
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

10.  Purification and characterization of recombinant human p50csk protein-tyrosine kinase from an Escherichia coli expression system overproducing the bacterial chaperones GroES and GroEL.

Authors:  K E Amrein; B Takacs; M Stieger; J Molnos; N A Flint; P Burn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

View more
  4 in total

1.  Chemoenzymatic Semi-synthesis Enables Efficient Production of Isotopically Labeled α-Synuclein with Site-Specific Tyrosine Phosphorylation.

Authors:  Buyan Pan; Joo Hyung Park; Trudy Ramlall; David Eliezer; Elizabeth Rhoades; E James Petersson
Journal:  Chembiochem       Date:  2021-01-29       Impact factor: 3.164

2.  Survey of solution dynamics in Src kinase reveals allosteric cross talk between the ligand binding and regulatory sites.

Authors:  Michael Tong; Jeff G Pelton; Michelle L Gill; Weibing Zhang; Francis Picart; Markus A Seeliger
Journal:  Nat Commun       Date:  2017-12-18       Impact factor: 14.919

3.  Atomic view of the energy landscape in the allosteric regulation of Abl kinase.

Authors:  Tamjeed Saleh; Paolo Rossi; Charalampos G Kalodimos
Journal:  Nat Struct Mol Biol       Date:  2017-09-25       Impact factor: 15.369

Review 4.  Semi-synthesis of labeled proteins for spectroscopic applications.

Authors:  Lucia De Rosa; Anna Russomanno; Alessandra Romanelli; Luca Domenico D'Andrea
Journal:  Molecules       Date:  2013-01-02       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.